Post-Myocardial Infarction Remodeling Prevention Therapy
Public ClinicalTrials.gov record NCT01213251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the feasibility of pacing as a therapy to prevent adverse remodeling of the myocardium following an acute myocardial infarction (MI) in patients at highest risk for adverse myocardial remodeling.
Study identification
- NCT ID
- NCT01213251
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 129 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Sep 30, 2015
- Completion
- Mar 31, 2016
- Last update posted
- Dec 14, 2016
2010 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arrhythmia Consultants | Scottsdale | Arizona | 85251 | — |
| Kaiser Permanente | Los Angeles | California | 90027 | — |
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | — |
| Lexington Cardiac Research Foundation | Lexington | Kentucky | 40503 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Michigan Heart, PC | Ypsilanti | Michigan | 48197 | — |
| Carolina Heart Specialists | Gastonia | North Carolina | 28054 | — |
| Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| The Chattanooga Heart Institute | Chattanooga | Tennessee | 37404 | — |
| The Stern Cardiovascular Foundation | Germantown | Tennessee | 38138 | — |
| Saint Thomas Research Institute, LLC | Nashville | Tennessee | 37205 | — |
| Baylor Jack and Jane Hamilton Heart and Vascular Hospital | Dallas | Texas | 75226 | — |
| Delgado Cardiovascular Associates | Houston | Texas | 77004 | — |
| Spokane Cardiology | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01213251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01213251 live on ClinicalTrials.gov.